We first analysed whether various factors, such as age, expression of the TARDBP gene, radiotherapy [22, 23], and TMZ chemotherapy [22, 23], were related to the survival prognosis of glioma patients. The gene discussed is TARDBP; the disease is central nervous system cancer.